Brentuximab vedotin exerts profound antiproliferative and pro‐apoptotic efficacy in CD30‐positive as well as cocultured CD30‐negative germ cell tumour cell lines

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|22|1|568-575

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.22, Iss.1, 2018-01, pp. : 568-575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic benefits of CD90‐negative cardiac stromal cells in rats with a 30‐day chronic infarct

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1984-1991

John Wiley & Sons Inc

Access to resources Recommend Favorite

The CD4+AT2R+ T cell subpopulation improves post‐infarction remodelling and restores cardiac function

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 8, 2015-08 ,pp. : 1975-1985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiac telocytes are double positive for CD34/PDGFR‐α

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 8, 2015-08 ,pp. : 2036-2042

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dedifferentiation of patient‐derived glioblastoma multiforme cell lines results in a cancer stem cell‐like state with mitogen‐independent growth

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 6, 2015-06 ,pp. : 1262-1272

John Wiley & Sons Inc

Access to resources Recommend Favorite

The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 2, 2018-02 ,pp. : 1257-1271

John Wiley & Sons Inc

Access to resources Recommend Favorite